BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 26, 2021
View Archived Issues
Phase I trial evaluates [11C]YJH-08 PET imaging of GR expression in metastatic prostate cancer
Read More
Camino studies SBP-9330 in first-in-human trial for smoking cessation
Read More
New Toll-like receptor 7 agonists identified at Bristol Myers Squibb
Read More
Vertex Pharmaceuticals presents new apolipoprotein L1 inhibitors
Read More
New CREB-2 inhibitors discovered at Evotec International
Read More
Memorial Sloan-Kettering Cancer Center describes prodrugs useful in adoptive cell therapy
Read More
Mutational profiling gives clues to development, new puzzles about disease
Read More
Blade receives IND clearance for phase I study of cudetaxestat for IPF
Read More
Data presented for Almirall's JAK inhibitor LAS-200019
Read More
Janssen targets DHODH with new compounds for acute myelogenous leukemia
Read More
HUTCHMED begins phase Ib/II study of fruquintinib with tislelizumab in TNBC and endometrial cancer
Read More
New phase I/II trial investigates RVU-120 in relapsed/refractory metastatic or advanced solid tumors
Read More
CPI-613 advances into phase II evaluation in biliary tract cancer
Read More
Phase II trial of izokibep in ankylosing spondylitis commences dosing
Read More
Epeleuton shows promise in hamster model for SARS-CoV-2 infection
Read More
Mutation in RAPGEF1 gene tied to global developmental delay syndrome
Read More
Phase II study of SHR-0302 in alopecia areata meets primary efficacy endpoint
Read More
Studies reveal efficacy and mechanism of SARS-CoV-2-neutralizing antibody SC-31
Read More